MedPath

Study the Effect of Oral Zinc Supplementation on High Molecular Weight Zinc Binding Protein in Semen

Completed
Conditions
Asthenozoospermia
Interventions
Dietary Supplement: zinc sulfate
Registration Number
NCT01612403
Lead Sponsor
mahmoud hussein hadwan
Brief Summary

There are several causes leading to male infertility, like oxidative stress, and nutritional deficiency of trace elements like zinc. Zinc in human seminal plasma was divided into three types of ligands which are high (HMW), intermediate (IMW), and low molecular weight ligands (LMW). The present study was conducted to study the effect of Zn supplementation on the quantitative and qualitative characteristics of semen along with Zinc Binding Protein levels in semen of patients with asthenozoospmia.

Detailed Description

Elevation of ROS levels lead to an increase the oxidation of HMW-Zn binding proteins in seminal plasma of asthenozoospermic subjects. Zinc supplementation restores HMW-Zn% in seminal plasma of asthenozoospermic subjects to normal value. LMW-Zn% is elevated in seminal plasma of asthenozoospermic patients. It may be because increment the levels of semenogelin in seminal plasma of asthenozoospermic subjects. Zinc supplementation elevates LMW-Zn% in seminal plasma of asthenozoospermic subjects to more than normal value, this may be because of its enhancement of the synthesis of metallothioneins (Low molecular weight zinc binding protein).

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
37
Inclusion Criteria

The inclusion criteria were the presence of asthenozoospermia in the semen sample.

Exclusion Criteria
  • the absence of endocrinopathy,
  • varicocele, and
  • female factor infertility. Smokers and alcoholic men were excluded from the study because of their recognized high seminal ROS levels and decreased antioxidant levels.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Single groupzinc sulfateSingle group: all participants receive same intervention throughout study (Non-randomised)
Primary Outcome Measures
NameTimeMethod
high molecular weight zinc binding proteinat the end of three months

elevated levels of high molecular weight zinc binding protein to normal value

Secondary Outcome Measures
NameTimeMethod
qualitative semen parametersat the end of three months

Volume of semen, progressive sperm motility percentage and total normal sperm count increased after zinc sulfate supplementation.

Trial Locations

Locations (2)

Babylon University

🇮🇶

Hilla, Iraq

Babylon university/ college of science

🇮🇶

Hilla, Iraq

© Copyright 2025. All Rights Reserved by MedPath